Kirby McInerney LLP is investigating HCA Healthcare for potential securities fraud following the company's sharp profit guidance cut due to increased uninsured patients affecting revenue by $400 million. The investigation aims to determine if HCA or its executives violated federal securities laws. HCA's stock fell nearly 7% after the announcement. No lawsuit has been filed yet, and the investigation is ongoing.
Wells Fargo has lowered its price target for HCA Healthcare to $369 from $428 following the company's revised 2026 financial outlook. HCA Healthcare reduced its earnings per share forecast to $28.70-$30.50 and narrowed sales guidance to $77-$79.5 bil...
HCA Healthcare announced a significant cut to its full-year 2026 profit guidance due to an unfavorable change in its payer mix, which reduced revenue by about $400 million in Q2. Following this announcement, HCA's stock price fell nearly 7%. Pomerant...
